<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03022669</url>
  </required_header>
  <id_info>
    <org_study_id>1IK3HX002055-01A1</org_study_id>
    <nct_id>NCT03022669</nct_id>
  </id_info>
  <brief_title>Mobile Health Strategies for Veterans</brief_title>
  <official_title>Mobile Health Strategies for Veterans With Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>San Francisco Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether text messages/messaging (TM) or a mobile
      application (app), compared with an educational website-control provided to all Veterans, can
      improve adherence to antiplatelet therapy among patients following acute coronary syndrome or
      percutaneous coronary intervention (ACS/PCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adherence to antiplatelet medications is critical to prevent life threatening complications
      (i.e., stent thrombosis); yet rates of non-adherence range from 21-57% by 12 months. Mobile
      technology through TM or mobile apps is a practical and inexpensive strategy to promote
      behavior change and enhance medication adherence. The three specific aims of this proposal
      are to: 1) determine preferences for content and frequency of TM to promote medication
      adherence through focus groups; 2) determine the most patient-centered app to promote
      adherence through a content analysis of all commercially available apps for medication
      adherence and focus groups centered on usability; and 3) compare adherence to antiplatelet
      medications in 225 Veterans post ACS/PCI through a randomized controlled trial. Participants
      will be randomized to either TM, mobile app, or website-control group. The focus groups will
      be stratified by low/high mobile phone use and sex.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication adherence</measure>
    <time_frame>In person follow-up visits will occur at 1, 6, and 12 months, while monitoring of adherence through refill data from computer software will be done monthly to reduce participant burden.</time_frame>
    <description>Medication adherence will be assessed with five different measures at various intervals to validate patterns of adherence including Medication Event Monitoring System (MEMS, Key Primary Endpoint - percentage of prescribed doses taken), Morisky Medication Adherence Scale, 7 day recall, VA Corporate Data Warehouse (Veterans), and Peoplechart Meds IncontextTM (non-Veterans).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Text Message Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The &quot;TM group&quot; will use the VA &quot;Annie&quot; text messaging program to remind patients to take antiplatelet medications. The content for the text messages will be determined through preliminary focus groups that will be conducted prior to the RCT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Application Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The &quot;App group&quot; will use a mobile application to remind patients to take antiplatelet medications. The commercially available mobile app will be selected by participants through preliminary focus groups that will be conducted prior to the RCT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Website-Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The &quot;Website-Control group&quot; will will be offered the American Heart Association patient education website (My Life Check - 7 Steps To Healthy Living) and will serve as an &quot;attention-control.&quot; The website will be offered to participants in all three groups. The &quot;7 small steps to big changes&quot; are to manage blood pressure, control cholesterol, reduce blood sugar, get active, eat better, lose weight, and stop smoking.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text Message</intervention_name>
    <description>Annie (VA text messaging program) or mobile Health manager (private text messaging program for non-VA female participants recruited at non-VA facility)</description>
    <arm_group_label>Text Message Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile Application</intervention_name>
    <arm_group_label>Application Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Website</intervention_name>
    <description>American Heart Association patient education website</description>
    <arm_group_label>Text Message Group</arm_group_label>
    <arm_group_label>Application Group</arm_group_label>
    <arm_group_label>Website-Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â‰¥ 21 years of age,

          -  recent ACS or PCI within 1 week

          -  new antiplatelet (thienopyridine) prescription

        Exclusion Criteria:

          -  cognitive impairment

          -  lack of English proficiency/literacy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Park, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Francisco Veterans Medical Center; University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Linda Park, PhD, MS, FNP</last_name>
    <email>Linda.Park@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephanie Merek, MPH</last_name>
    <phone>415-221-4810</phone>
    <phone_ext>26379</phone_ext>
    <email>stephanie.merek@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John Muir Medical Center</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tish Murphy, RN, MBA</last_name>
      <phone>925-674-2198</phone>
      <email>tish.murphy@johnmuirhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Francisco Veterans Affairs Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Merek, MPH</last_name>
      <phone>415-221-4810</phone>
      <phone_ext>26379</phone_ext>
      <email>stephanie.merek@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Mark Pabst, MPH</last_name>
      <phone>415-221-4810</phone>
      <phone_ext>224432</phone_ext>
      <email>mark.pabst@va.gov</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2017</study_first_submitted>
  <study_first_submitted_qc>January 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2017</study_first_posted>
  <last_update_submitted>January 12, 2017</last_update_submitted>
  <last_update_submitted_qc>January 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Linda Park</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>mobile health</keyword>
  <keyword>veterans</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>medication adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

